Patents by Inventor Matthias Hinzpeter

Matthias Hinzpeter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7255859
    Abstract: The invention concerns monoclonal antibodies against the epitope YPYDVPDYA (SEQ ID NO: 1) which is derived from the haemagglutinin of the human influenza virus and are suitable for the detection and isolation of native haemagglutinin of the human influenza virus, of modified haemagglutinin or of haemagglutinin fusion proteins and have an affinity of >108 M?1, in particular of 109 to 1010 M?1.
    Type: Grant
    Filed: October 20, 1997
    Date of Patent: August 14, 2007
    Assignee: Roche Diagnostics GmbH
    Inventors: Thomas Emrich, Matthias Hinzpeter, Michael Grol
  • Patent number: 6221584
    Abstract: The invention concerns a method for the detection of telomerase activity wherein (a) a sample to be tested is provided, (b) a first primer suitable as a telomerase substrate and nucleoside triphosphates are added and the reaction mixture is incubated under conditions under which a primer extension by the telomerase can take place, (c) an amplification of the extension product produced by the telomerase is carried out, (d) the amplification product produced in step (c) is immobilized on a solid phase and (e) the immobilized amplification product is detected qualitatively or/and quantitatively. Furthermore the invention concerns a suitable reagent kit for carrying out the method.
    Type: Grant
    Filed: December 29, 1997
    Date of Patent: April 24, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Thomas Emrich, Hermann Leying, Matthias Hinzpeter, Gerlinde Karl
  • Patent number: 6136531
    Abstract: The invention describes a method of quantitatively detecting specific nucleotide sequences. Said method is essentially characterized in that a single-stranded nucleic acid, particularly mRNA, which has been isolated from a mixture, e.g. a biological sample, is hybridized in solution, with a polynucleotide sequence which is essentially complementary to the sequence to be determined; the nucleic acid is then immobilized on a solid phase, and the amount of bound hybrid is determined. It has proven to be particularly advantageous if the binding to the coated solid phase is accomplished with the aid of the specifically bindable chemical group which is coupled to the sequence to be determined or to the polynucleotide probe sequence via a linker.
    Type: Grant
    Filed: October 29, 1997
    Date of Patent: October 24, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Hermann Leying, Matthias Hinzpeter, Hans-Peter Fritton, Clemens Doppler, Heiko Wittor
  • Patent number: 6027886
    Abstract: Method and kit for the quantitative detection of specific oligonucleotide or polynucleotide sequences which is characterized in that a sample mixture containing RNA or single-stranded DNA is hybridized with an oligonucleotide or polynucleotide probe(s) which are complementary to the nucleotide sequence to be determined and carry(ies) a specificplly bindable and a detectable chemical group subsequently it is admixed with an agent that cleaves single-stranded polynucleotide sequences and the immobilized or non-immobilized nucleotide probe is determined after transfer into a suitable reaction vessel. It has proven to be particularly advantageous when a mixture is used which is composed of different cleaving reagents.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: February 22, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Hermann Leying, Matthias Hinzpeter, Heiko Wittor, Hans-Peter Fritton
  • Patent number: 5955271
    Abstract: The invention involves methods and kits useful in determining specific mRNA molecules. The methods can be carried in a single reaction vessel, in that both reverse transcriptase and amplification can be carried out in the same, heat stable reaction vessel.
    Type: Grant
    Filed: July 22, 1996
    Date of Patent: September 21, 1999
    Assignee: Boehringer Mannheim GmbH
    Inventors: Hermann Leying, Matthias Hinzpeter, Hans-Peter Fritton, Heiko Wittor
  • Patent number: 5700639
    Abstract: The invention concerns a method for the non-radioactive detection of metabolically labelled DNA, in one aspect detecting labelled DNA indicative of cell lysis or apoptosis.
    Type: Grant
    Filed: June 9, 1994
    Date of Patent: December 23, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Bernhard Trauth, Matthias Hinzpeter, Clemens Doppler, Eberhard Russmann
  • Patent number: 5455157
    Abstract: For the determination of the rate of nucleic acid synthesis in eukaryotic cells a nucleotide which is non-radioactively labelled or derivatized with a hapten is introduced into the cells with the addition of liposomes and the rate of synthesis of the nucleic acids is determined by means of the incorporation of the nucleotide via its label or derivatization.
    Type: Grant
    Filed: April 19, 1994
    Date of Patent: October 3, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Matthias Hinzpeter, Herbert von der Eltz